Bonds backed by pools of consumer or business loans (auto, credit card, student loans).
Similar structure to MBS but with non-mortgage collateral. Tranched by credit quality. Generally safer than MBS due to shorter duration and more diversified collateral. Auto ABS is the largest segment.
Bonds backed by pools of consumer or business loans (auto, credit card, student loans). Similar structure to MBS but with non-mortgage collateral. Tranched by credit quality. Generally safer than MBS due to shorter duration and more diversified collateral. Auto ABS is the largest segment.
In bonds, ABS (Asset-Backed Securities) is one of the building blocks investors use to compare opportunities and assess risk. Understanding it helps you read research notes, earnings reports, and market commentary without getting lost in jargon.
Similar structure to MBS but with non-mortgage collateral. Tranched by credit quality.
The Quick Take * Pine Labs has utilized ₹974.95 crore of its ₹2,080 crore IPO proceeds as of June 2026, with the Shopflo acquisition and international subsidiary investments leading capital deployment * The fintech company completed the ₹65.99 crore acquisition of Shopflo, adding checkout and merchant commerce capabilities to its payment infrastructure platform * Pine Labs is deploying fresh IPO capital across its Singapore, Malaysia, and UAE subsidiaries as it pursues an international expan
Jul 30, 2026
Laurus Labs shares hit an all-time record high following multiple analyst upgrades post-Q1 results
Jul 28, 2026
Mobix Labs (MOBX) announced plans to rebrand as NSM Labs following an acquisition agreement, signaling a strategic repositioning of the RF communications semiconductor company
Jul 28, 2026
The Quick Take * Laurus Labs Q1 FY27 net profit surged 126% YoY to ₹368 crore, driven by CDMO (contract development and manufacturing) strength * CDMO business is the structural growth engine, signalling Laurus has successfully pivoted from generic APIs to high-value synthesis contracts * Result validates management's multi-year strategy to build a global CDMO franchise alongside its pharma API core Laurus Labs (NSE: LAURUSLABS) delivered a standout Q1FY27, with net profit jumping 126% year
Jul 27, 2026
Looking for more financial terms?
Browse Full Glossary →